Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-000673
Filing Date
2023-01-04
Accepted
2023-01-04 17:35:35
Documents
1
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8122
  Complete submission text file 0000899243-23-000673.txt   9478
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A CRESTWOOD KY 40014
Business Address
Dunlop A. Sinclair (Reporting) CIK: 0001721108 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 23508297